⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
SNY News
Sanofi American Depositary Shares (Each representing one-half of one ordinary share)
NFT in Healthcare Market Forecasts From USD 250 Mn in 2025 to USD 1,142.77 Mn by 2034 - Trends, Drivers & Strategic Outlook
globenewswire.com
HUM
UNH
PFE
SNY
$191.2 Million Achromatopsia Market Outlook, 2026-2032, Featuring Adverum Biotechnologies, Homology Medicines, Mattel, REGENXBIO, Sanofi and More
globenewswire.com
ADVM
MAT
SNY
Macrophage Activation Syndrome Market in the 6MM to Witness Upsurge in Growth at a CAGR of 24.7% During the Forecast Period (2025-2034) | DelveInsight
prnewswire.com
NVS
BIIB
VTRS
UCB
BMY
ABBV
REGN
SNY
LLY
JNJ
HOPE
GCBC
AMGN
TAK
Inflammatory Diseases Biologics Market to Reach USD 157.31 Billion by 2033 as Targeted Immunology Therapies Redefine Long-Term Disease Control
prnewswire.com
AMGN
NVS
JNJ
PFE
GSK
ABBV
SNY
LLY
diaTribe Convenes International Consensus to Guide Diabetes Technology Use During Pregnancy
prnewswire.com
BIIB
AMGN
LLY
JNJ
PFE
MRK
BMY
GILD
REGN
AZN
ABBV
SNY
NVO
LULU
GOOG
MSFT
AMZN
META
TSLA
NVDA
XOM
CVX
KO
PEP
MCD
DIS
BA
CAT
GS
JPM
BAC
WFC
C
T
VZ
CMCSA
NFLX
ADBE
CRM
INTC
QCOM
AMD
CSCO
HON
GE
IBM
ORCL
SAP
ACN
MU
AMAT
LRCX
ADI
TXN
NXPI
MRVL
MCHP
PYPL
CMG
SBUX
NKE
HD
PG
UNH
ELV
CVS
CI
HCA
MCK
CAH
Recludix Pharma Announces Equity Financing to Advance Clinical Development of Novel SH2 Domain Inhibitors
globenewswire.com
SNY
Recludix Pharma Announces Dosing of First Subjects in a Phase 1 Study of REX-8756, a Potent and Selective Oral STAT6 Inhibitor, and Achieves Associated $20 Million Milestone Payment Under Collaboration with Sanofi
globenewswire.com
SNY
Biomedical and ICT Convergence Market Research Report 2025-2030: Opportunities in Developing Connected Medical Devices, Enhancing Precision Medicine, and Improving Healthcare Delivery
globenewswire.com
ABT
AMGN
ADI
AZN
BIIB
BIO
XRAY
GEHC
GILD
HON
JNJ
MDLZ
MRK
NVS
NVO
NXPI
PFE
SNY
SWX
STM
TEI
TXN
TMO
ZBH
FMS
JBL
LMT
MDT
ON
PHI
SYK
WMT
Press Release: Sanofi’s Teizeild approved in the EU for patients with stage 2 type 1 diabetes
globenewswire.com
SNY
Alamar Biosciences gibt Abschluss der überzeichneten Wandelanleihe-Finanzierung und Erweiterung des Führungsteams bekannt USA - Deutsch USA - Français USA - English APAC - English USA - English USA - čeština
prnewswire.com
AMGN
ILMN
VRTX
RIVN
TROW
PRGS
ALNY
REGN
GILD
BMY
MRK
ABBV
AZN
SNY
NVS
XRAY
EVTC
MYGN
RVTY
VTRS
BIIB
MDLZ
PFE
SNDX
EXAS
CRSP
NTRA
ON
IDXX
MDT
SYK
ISRG
DXCM
COO
AMZN
GOOG
MSFT
NVDA
IBM
INTC
QCOM
AMD
MU
ADBE
CRM
ORCL
SAP
CSCO
ACN
HPQ
DELL
MSCI
FIS
PAYX
ADP
BBBY
ROST
TJX
MCHP
NXPI
SNPS
CDNS
WDC
STX
KLAC
LRCX
AMAT
CTAS
PAYC
NOW
DDOG
ZS
PANW
FTNT
SNOW
PYPL
V
MA
AXP
BAC
JPM
WFC
C
GS
MS
SCHW
ELAN
ZTS
ALGN
XOM
CVX
KO
PEP
MCD
DIS
CMCSA
VZ
T
NFLX